Cargando…

Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects

BACKGROUND: Eight extracts from common native allergens, Artemisia annua pollen, Platanus pollen, Humulus pollen, Betula platyphylla pollen, Ambrosia artemisiifolia pollen, Blattella germanica, cat dander and dog dander were developed for skin prick test (SPT). Since standardization and composition...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Xiaoyi, Kuang, Yun, Zhao, Shuwei, Hou, Wenjing, Yang, Guoping, Zhu, Xuerui, Liu, Ruiling, Huang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568631/
https://www.ncbi.nlm.nih.gov/pubmed/33116655
http://dx.doi.org/10.2147/JAA.S276720
_version_ 1783596562338807808
author Ning, Xiaoyi
Kuang, Yun
Zhao, Shuwei
Hou, Wenjing
Yang, Guoping
Zhu, Xuerui
Liu, Ruiling
Huang, Jie
author_facet Ning, Xiaoyi
Kuang, Yun
Zhao, Shuwei
Hou, Wenjing
Yang, Guoping
Zhu, Xuerui
Liu, Ruiling
Huang, Jie
author_sort Ning, Xiaoyi
collection PubMed
description BACKGROUND: Eight extracts from common native allergens, Artemisia annua pollen, Platanus pollen, Humulus pollen, Betula platyphylla pollen, Ambrosia artemisiifolia pollen, Blattella germanica, cat dander and dog dander were developed for skin prick test (SPT). Since standardization and composition alone cannot guarantee that the allergen extracts are within the concentration range that give the best chance of a true diagnosis, it is necessary to explore the optimal diagnostic concentration (ODC) of allergens in SPT. OBJECTIVE: To identify the optimal diagnostic concentration of eight allergen extracts in SPT and assess the safety of simultaneous administration. PATIENTS AND METHODS: Patients with a history of allergic disease were enrolled in this two-part open-label, parallel study. In Study 1, 92 patients were enrolled into eight groups according to their disease-causing allergens and were given three increasing concentrations of the corresponding allergen. In Study 2, 20 patients were divided into two concentration groups and were given all of the eight allergens. Safety and sensitivity were evaluated to determine the optimal diagnostic concentration. RESULTS: In Study 1, the sensitivity of seven allergen extracts was >80% at middle and high concentrations, except for Ambrosia artemisiifolia pollen. The optimal diagnostic concentration (in DU/mL) for eight allergens was 33,333, 12,000, 8667, 50,000, 40,000, 3333, 7000, and 5000. In Study 2, the prevalence of adverse events in the two groups was 70% and 80%, respectively. A total of 10 wheals of 8 patients did not subside <24 h after SPTs. CONCLUSION: The eight allergens showed high sensitivity and safety at a certain concentration, which was defined as optimal diagnostic concentration. The results support further clinical research of investigated allergens and our study offers a scheme to determine the ODC of allergens in SPT.
format Online
Article
Text
id pubmed-7568631
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75686312020-10-27 Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects Ning, Xiaoyi Kuang, Yun Zhao, Shuwei Hou, Wenjing Yang, Guoping Zhu, Xuerui Liu, Ruiling Huang, Jie J Asthma Allergy Original Research BACKGROUND: Eight extracts from common native allergens, Artemisia annua pollen, Platanus pollen, Humulus pollen, Betula platyphylla pollen, Ambrosia artemisiifolia pollen, Blattella germanica, cat dander and dog dander were developed for skin prick test (SPT). Since standardization and composition alone cannot guarantee that the allergen extracts are within the concentration range that give the best chance of a true diagnosis, it is necessary to explore the optimal diagnostic concentration (ODC) of allergens in SPT. OBJECTIVE: To identify the optimal diagnostic concentration of eight allergen extracts in SPT and assess the safety of simultaneous administration. PATIENTS AND METHODS: Patients with a history of allergic disease were enrolled in this two-part open-label, parallel study. In Study 1, 92 patients were enrolled into eight groups according to their disease-causing allergens and were given three increasing concentrations of the corresponding allergen. In Study 2, 20 patients were divided into two concentration groups and were given all of the eight allergens. Safety and sensitivity were evaluated to determine the optimal diagnostic concentration. RESULTS: In Study 1, the sensitivity of seven allergen extracts was >80% at middle and high concentrations, except for Ambrosia artemisiifolia pollen. The optimal diagnostic concentration (in DU/mL) for eight allergens was 33,333, 12,000, 8667, 50,000, 40,000, 3333, 7000, and 5000. In Study 2, the prevalence of adverse events in the two groups was 70% and 80%, respectively. A total of 10 wheals of 8 patients did not subside <24 h after SPTs. CONCLUSION: The eight allergens showed high sensitivity and safety at a certain concentration, which was defined as optimal diagnostic concentration. The results support further clinical research of investigated allergens and our study offers a scheme to determine the ODC of allergens in SPT. Dove 2020-10-13 /pmc/articles/PMC7568631/ /pubmed/33116655 http://dx.doi.org/10.2147/JAA.S276720 Text en © 2020 Ning et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ning, Xiaoyi
Kuang, Yun
Zhao, Shuwei
Hou, Wenjing
Yang, Guoping
Zhu, Xuerui
Liu, Ruiling
Huang, Jie
Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects
title Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects
title_full Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects
title_fullStr Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects
title_full_unstemmed Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects
title_short Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects
title_sort design of an optimally-diagnostic skin test for diagnosis of sensitivity to eight allergens: a first-in-human study of dose escalation and simultaneous administration in chinese subjects
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568631/
https://www.ncbi.nlm.nih.gov/pubmed/33116655
http://dx.doi.org/10.2147/JAA.S276720
work_keys_str_mv AT ningxiaoyi designofanoptimallydiagnosticskintestfordiagnosisofsensitivitytoeightallergensafirstinhumanstudyofdoseescalationandsimultaneousadministrationinchinesesubjects
AT kuangyun designofanoptimallydiagnosticskintestfordiagnosisofsensitivitytoeightallergensafirstinhumanstudyofdoseescalationandsimultaneousadministrationinchinesesubjects
AT zhaoshuwei designofanoptimallydiagnosticskintestfordiagnosisofsensitivitytoeightallergensafirstinhumanstudyofdoseescalationandsimultaneousadministrationinchinesesubjects
AT houwenjing designofanoptimallydiagnosticskintestfordiagnosisofsensitivitytoeightallergensafirstinhumanstudyofdoseescalationandsimultaneousadministrationinchinesesubjects
AT yangguoping designofanoptimallydiagnosticskintestfordiagnosisofsensitivitytoeightallergensafirstinhumanstudyofdoseescalationandsimultaneousadministrationinchinesesubjects
AT zhuxuerui designofanoptimallydiagnosticskintestfordiagnosisofsensitivitytoeightallergensafirstinhumanstudyofdoseescalationandsimultaneousadministrationinchinesesubjects
AT liuruiling designofanoptimallydiagnosticskintestfordiagnosisofsensitivitytoeightallergensafirstinhumanstudyofdoseescalationandsimultaneousadministrationinchinesesubjects
AT huangjie designofanoptimallydiagnosticskintestfordiagnosisofsensitivitytoeightallergensafirstinhumanstudyofdoseescalationandsimultaneousadministrationinchinesesubjects